Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
Not Applicable
Completed
- Conditions
 - Hepatocellular CarcinomaBile Duct CancerPancreatic CancerColorectal CarcinomaLiver MetastasesPrimary Liver CancerGallbladder Cancer
 
- Registration Number
 - NCT01640522
 
- Lead Sponsor
 - University of Pittsburgh
 
- Brief Summary
 The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.
- Detailed Description
 The study is a collaborative care intervention designed to reduce pain, fatigue, and depressive symptoms and improve overall health related quality of life.
Recruitment & Eligibility
- Status
 - COMPLETED
 
- Sex
 - All
 
- Target Recruitment
 - 261
 
Inclusion Criteria
- biopsy, radiological, and/or biological evidence of hepatobiliary carcinoma
 - age 18 years or older
 - fluency in English. Exclusion criteria included:
 
Exclusion Criteria
- current suicidal or homicidal ideation
 - current psychosis or thought disorder
 
Study & Design
- Study Type
 - INTERVENTIONAL
 
- Study Design
 - PARALLEL
 
- Primary Outcome Measures
 Name Time Method Depression Change from baseline at 6 and 12 months Center for Epidemiological Studies-Depression scale
- Secondary Outcome Measures
 Name Time Method Fatigue Change from baseline at 6 and 12 months Functional Assessment of Cancer Therapy-Fatigue
Trial Locations
- Locations (1)
 University of Pittsburgh Medical Center
🇺🇸Pittsburgh, Pennsylvania, United States
University of Pittsburgh Medical Center🇺🇸Pittsburgh, Pennsylvania, United States
